Diagnosing this disease can be complicated because it shows up in many different ways, and the tests available to identify it have limitations
Among respondents currently taking a GLP1, one quarter said they are paying the full cost out of pocket
What kind of privacy do they have
In SURMOUNT-1, a study in 2,539 adults with obesity, or excess weight and weight-related medical problems not including diabetes, people taking Zepbound as an adjunct to diet and exercise experienced substantial weight loss compared with placebo at 72 weeks
doi: 10.1007/s002590000309 127 ZhaZPloesslKChoiSRWuZZhuLKungHF
Stephens, F.B., Wall, B.T., Marimuthu, K., Shannon, C.E., Constantin-Teodosiu, D., Macdonald, I.A., Greenhaff, P.L